Skip to main content

Piperacillin and Tazobactam

NDC 65219-256 · Fresenius Kabi USA, LLC

FDA carries 3 listing records for this NDC; the most recent is shown.

Generic namePiperacillin and Tazobactam
Dosage formINJECTION, POWDER, FOR SOLUTION
RouteINTRAVENOUS
Active ingredient(s)PIPERACILLIN SODIUM, TAZOBACTAM SODIUM
Strength36; 4.5 g/180mL; g/180mL
Pharmacologic classPenicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]
Marketing categoryANDA

Packages

65219-256-28 — 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (65219-256-28) / 180 mL in 1 VIAL, PHARMACY BULK PACKAGE

65219-256-24 — 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (65219-256-24) / 180 mL in 1 VIAL, PHARMACY BULK PACKAGE

65219-256-00 — 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (65219-256-00) / 180 mL in 1 VIAL, PHARMACY BULK PACKAGE

Billed under HCPCS

J2543 — Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) Medicare Part B payment limit (ASP + 6%): $1.22

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

60505-6157 — PIPERACILLIN and TAZOBACTAM, 60505-6159 — PIPERACILLIN and TAZOBACTAM, 60505-6262 — Piperacillin and Tazobactam, 63323-300 — PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, 63323-304 — Piperacillin Sodium and Tazobactam Sodium, 63323-309 — PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, 63323-320 — PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, 63323-981 — Piperacillin and Tazobactam, 63323-982 — Piperacillin and Tazobactam, 63323-983 — Piperacillin and Tazobactam, 65219-259 — Piperacillin and Tazobactam, 65219-434 — Piperacillin and Tazobactam, 65219-436 — Piperacillin and Tazobactam, 67919-030 — ceftolozane and tazobactam, 68001-506 — PIPERACILLIN and TAZOBACTAM, 68001-507 — PIPERACILLIN and TAZOBACTAM, 68001-508 — PIPERACILLIN and TAZOBACTAM, 72485-403 — piperacillin and tazobactam, 72485-404 — piperacillin and tazobactam, 72572-414 — piperacillin and tazobactam, +48 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels